G(M2) Ganglioside
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis (NCT00679744) | Exsar Corporation | 2008-05-01 |
Track G(M2) Ganglioside automatically
Every clearance here is in the API, with alerts when new ones post.